Peritransplant Cyclosporine in Treating Patients With Hematologic Malignancies Undergoing T-Cell Depleted Allogeneic Stem Cell Transplant Followed By T-Cell Add-Back
This study is ongoing, but not recruiting participants.
Study NCT00079391
Information provided by National Cancer Institute (NCI)
First Received: March 8, 2004
Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
